Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1007/s40261-023-01316-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factor VIII Inhibitor Bypassing Activity (FEIBA) Reversal for Apixaban and Rivaroxaban in Patients With Acute Intracranial and Nonintracranial Hemorrhage
- (2021) Aleah R. Hunt et al. ANNALS OF PHARMACOTHERAPY
- A review of guidelines on anticoagulation reversal across different clinical scenarios – Is there a general consensus?
- (2020) Truman J. Milling et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Trends in anticoagulant prescribing: a review of local policies in English primary care
- (2020) Katherine H. Ho et al. BMC HEALTH SERVICES RESEARCH
- Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
- (2020) Renee Castillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study
- (2019) Melanie N. Smith et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Current status of oral anticoagulant reversal strategies: a review
- (2019) Aranyak Rawal et al. Annals of Translational Medicine
- Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding
- (2019) Marwan Sheikh-Taha et al. American Journal of Cardiovascular Drugs
- Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban
- (2019) Marwan Sheikh-Taha Internal and Emergency Medicine
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
- (2018) Peter Gross et al. THROMBOSIS AND HAEMOSTASIS
- Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate
- (2018) Marwan Sheikh-Taha Internal and Emergency Medicine
- National Trends in Ambulatory Oral Anticoagulant Use
- (2015) Geoffrey D. Barnes et al. AMERICAN JOURNAL OF MEDICINE
- Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH
- (2015) N. Khorsand et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
- (2015) Jennifer A. Frontera et al. Neurocritical Care
- Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
- (2013) Ravi Sarode et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search